BOEHRINGER INGELHEIM : SURVODUTIDE DOES NOT INCREASE RISK OF CARDIOVASCULAR DEATH, NON-FATAL STROKE OR MI VERSUS PLACEBO

Reuters · 2d ago

Please log in to view news